
zzso zzso constitutes a new complication of this therapeutic zzso It is characterized by loss of fat from the face and limbs and zzso of fat in the abdominal wall zzso simulating an abdominal zzso but also in the abdominal cavity zzso greater zzso zzso zzso This complication, whose frequency is currently assessed to be between 24 to zzso occurs an average of 10 months after starting zzso It is often accompanied by laboratory zzso such as zzso zzso or insulin zzso The zzso and long-term consequences of this complication are still poorly zzso 

